日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.

采用 EGFR-MET 双特异性抗体和 HER3 ADC 联合策略克服 NSCLC 中的奥希替尼耐药性。

Wang Yuanyuan, Guo Haoyue, Han Ruoshuang, Wu Yuhan, He Taiping, Diao Meng, Xiong Anwen, Zhou Fei, Cheng Lei, Zhao Chao, Li Xuefei, Zhou Caicun

Lipid Metabolism Related Gene ACSL3 as a Biomarker for Predicting Immunotherapy Outcomes in Lung Adenocarcinoma

脂质代谢相关基因ACSL3作为预测肺腺癌免疫治疗疗效的生物标志物

He, Taiping; Hu, Jinhan; Guo, Haoyue; Diao, Meng; Wang, Yuanyuan; Wu, Yuhan; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun

The pathogenesis and therapeutic management of rare pulmonary sarcomatoid carcinoma: a narrative review

罕见肺肉瘤样癌的发病机制和治疗管理:叙述性综述

Wang, Qianyi; Guo, Haoyue; Wang, Yuanyuan; He, Taiping; Diao, Meng; Wu, Yuhan; Xiong, Anwen; Zhou, Fei; Li, Wei; Cheng, Lei; Zhao, Chao; Li, Xuefei; Zhou, Caicun

Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer

Ascore 的多队列验证:基于细胞凋亡的预后特征,用于预测膀胱癌的疾病进展和免疫治疗反应

Tianlei Xie #, Shan Peng #, Shujun Liu #, Minghao Zheng, Wenli Diao, Meng Ding, Yao Fu, Hongqian Guo, Wei Zhao, Junlong Zhuang

WDR4 promotes the progression and lymphatic metastasis of bladder cancer via transcriptional down-regulation of ARRB2

WDR4通过转录下调ARRB2促进膀胱癌进展和淋巴转移

Guoli Wang #, Xin He #, Huiqi Dai #, Lingyi Lin, Wenmin Cao, Yao Fu, Wenli Diao, Meng Ding, Qing Zhang, Wei Chen, Hongqian Guo

Allosteric activation of the metabolic enzyme GPD1 inhibits bladder cancer growth via the lysoPC-PAFR-TRPV2 axis

代谢酶 GPD1 的变构激活通过 lysoPC-PAFR-TRPV2 轴抑制膀胱癌生长

Wenlong Zhang #, Xin He #, Haoli Yin #, Wenmin Cao, Tingsheng Lin, Wei Chen, Wenli Diao, Meng Ding, Hao Hu, Wenjing Mo, Qing Zhang, Hongqian Guo

circDHTKD1 promotes lymphatic metastasis of bladder cancer by upregulating CXCL5

circDHTKD1通过上调CXCL5促进膀胱癌淋巴转移

Qun Lu #, Haoli Yin #, Yongming Deng #, Wei Chen, Wenli Diao, Meng Ding, Wenmin Cao, Yao Fu, Wenjing Mo, Xiaoqing Chen, Qing Zhang, Xiaozhi Zhao, Hongqian Guo

Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers

泛癌症分析确定 LMNB1 是纠正 Th1/Th2 失衡和增强人类癌症中 PARP 抑制剂反应的目标

Haixiang Qin #, Yingqiang Lu #, Lin Du #, Jingyan Shi, Haoli Yin, Bo Jiang, Wei Chen, Wenli Diao, Meng Ding, Wenmin Cao, Xuefeng Qiu, Xiaozhi Zhao, Hongqian Guo

Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.

鉴定实验性糖尿病肾病发病机制中新的关键分子特征

Diao Meng, Wu Yimu, Yang Jialu, Liu Caiying, Xu Jinyuan, Jin Hongchao, Wang Juan, Zhang Jieping, Gao Furong, Jin Caixia, Tian Haibin, Xu Jingying, Ou Qingjian, Li Ying, Xu Guotong, Lu Lixia

The Potential Protective Effect of Iridoid Glycosides Isolated From Osmanthus fragrans Seeds Against the Development of Immune Liver Injury in Mice

桂花籽中分离的环烯醚萜苷对小鼠免疫性肝损伤的潜在保护作用

Yuchen Zhang, Feng Xiao, Qiqi Zhou, Tingting Diao, Meng Zhang, Dongyang Liu, Zhuowen Wang, Ting Huang, Yupei Wu, Yuting Bai, Qing Min